Dalquen P
Institut für Pathologie, Universität Basel.
Helv Chir Acta. 1990 Jan;56(5):689-700.
The various types of bronchial carcinoma are derived from pluripotent precursor cells of the respiratory epithelium. The direction of tumor differentiation depends on the locus of the genic mutation and therefore on the cancerogenic substance, on epigenetic gene amplification, and on autocrine regulations of the tumor cell population. The growth rate is the resultant of cell proliferation and cell loss by apoptosis. The formation of metastasis is determined by surface properties and implantation ability of the tumor cells. Age and state of lymph nodes are only loosely correlated with the biological behaviour of the tumors. It is possible to check the proliferative capacity of an individual tumor by immunocytochemistry and cytophotometry before any operative therapy. The extend of the preneoplastic lesions of the bronchial epithelium outside of the bronchial tumor, however, remains unknown. This explains why programs of early detection of bronchial cancer could not really improve long time survival and why surgical resection remain a palliative measure in most if not all cases.
各类支气管癌起源于呼吸道上皮的多能前体细胞。肿瘤分化的方向取决于基因突变的位点,因此取决于致癌物质、表观遗传基因扩增以及肿瘤细胞群体的自分泌调节。生长速率是细胞增殖和细胞凋亡导致细胞损失的结果。转移的形成由肿瘤细胞的表面特性和植入能力决定。年龄和淋巴结状态与肿瘤的生物学行为仅有松散的关联。在任何手术治疗之前,通过免疫细胞化学和细胞光度法可以检测单个肿瘤的增殖能力。然而,支气管肿瘤外支气管上皮的癌前病变范围仍然未知。这就解释了为什么支气管癌早期检测方案未能真正提高长期生存率,以及为什么在大多数(如果不是所有)情况下手术切除仍然是一种姑息性措施。